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Abstract
Serum and glucocorticoid-inducible kinase 1 (SGK1) is a protein kinase that
contributes to the hormonal control of renal Na+ retention by regulating the
abundance of epithelial Na+ channels (ENaC) at the apical surface of the prin-
cipal cells of the cortical collecting duct (CCD). Although glucocorticoids and
insulin stimulate Na+ transport by activating SGK1, the responses follow dif-
ferent time courses suggesting that these hormones act by different mecha-
nisms. We therefore explored the signaling pathways that allow
dexamethasone and insulin to stimulate Na+ transport in mouse CCD cells
(mpkCCDcl4). Dexamethasone evoked a progressive augmentation of electro-
genic Na+ transport that became apparent after ~45 min latency and was asso-
ciated with increases in SGK1 activity and abundance and with increased
expression of SGK1 mRNA. Although the catalytic activity of SGK1 is main-
tained by phosphatidylinositol-OH-3-kinase (PI3K), dexamethasone had no
effect upon PI3K activity. Insulin also stimulated Na+ transport but this
response occurred with no discernible latency. Moreover, although insulin also
activated SGK1, it had no effect upon SGK1 protein or mRNA abundance.
Insulin did, however, evoke a clear increase in cellular PI3K activity. Our data
are consistent with earlier work, which shows that glucocorticoids regulate
Na+ retention by inducing sgk1 gene expression, and also establish that this
occurs independently of increased PI3K activity. Insulin, on the other hand,
stimulates Na+ transport via a mechanism independent of sgk1 gene expres-
sion that involves PI3K activation. Although both hormones act via SGK1,
our data show that they activate this kinase by distinct physiological
mechanisms.
Introduction
Within the kidneys, ~99% of filtered Na+ is reabsorbed
via ion transport processes within the epithelia of the
renal tubules and, while most of this reabsorption occurs
via constitutively active Na+ transport systems in the
proximal nephron, the amount of Na+ recovered within
the distal nephron is under hormonal control. This regu-
lated process is therefore central to whole body sodium
and water homeostasis and the long-term regulation of
blood pressure (Blazer-Yost et al. 1998; De La Rosa et al.
2002; Loffing and Korbmacher 2009). Na+ retention
within this nephron segment is primarily controlled via
the renin–angiotensin–aldosterone system (RAAS), which
becomes active under conditions of hypovolemia and
hyponatremia. The final effector in this system is aldos-
terone, a steroid hormone that promotes Na+ retention
via the epithelial Na+ channel (ENaC) by binding to
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cytoplasmic mineralocorticoid receptors in the principal
cells of the cortical collecting duct. Many drugs used to
treat hypertension (angiotensin-converting enzyme inhibi-
tors, mineralocorticoid receptor antagonists) lower blood
pressure by disrupting the RAAS and thus promoting
diuresis/natriuresis. However, several other hormones
contribute to the control of Na+ transport in this
nephron segment (Loffing and Korbmacher 2009) and a
body of work suggests that inappropriate stimulation of
ENaC by glucocorticoids may contribute to the hyperten-
sion seen in conditions such as diabetes, obesity, and
metabolic syndrome that are characterized by glucocorti-
coid excess (Bailey et al. 2008, 2009; Hunter et al. 2014).
Moreover, as well as its role in carbohydrate metabolism,
insulin can also activate ENaC in the distal nephron (Bla-
zer-Yost et al. 1998; Loffing and Korbmacher 2009) and,
while this effect normally has little significance, it may
contribute to the hypertension and edema that can
develop in patients with type II diabetes who receive insu-
lin in combination with drugs that sensitize cells to this
hormone (see, e.g., Guan et al. 2005; Loffing and Korb-
macher 2009; Wilson et al. 2010). It is therefore
important to understand the mechanisms that allow glu-
cocorticoids and insulin to regulate Na+ retention within
the distal nephron, and earlier work indicates that both
hormones act via the serum and glucocorticoid-inducible
kinase 1 (SGK1), a protein kinase that contributes to the
control of Na+ retention by regulating the abundance of
ENaC at the cell surface (De La Rosa et al. 1999; Kobaya-
shi and Cohen 1999; Park et al. 1999; Wang et al. 2001;
Faletti et al. 2002; Loffing and Korbmacher 2009). How-
ever, despite this similarity, it is also clear that the
responses to dexamethasone, a synthetic glucocorticoid,
and insulin follow different time courses (see, e.g., Mans-
ley and Wilson 2010a, b) and this discrepancy suggests
that these hormones may act via different mechanisms.
This study therefore compares the effects of these hor-
mones upon the activity/abundance of SGK1 in mouse
cortical collecting duct cells. By combining these methods
with electrometric assays of ENaC activity we have
defined the mechanisms that allow these hormones to
control ENaC-mediated Na+ transport. While dexametha-
sone and insulin both increase SGK1 activity, these hor-
mones control this regulatory kinase via physiologically
distinct signaling pathways that can function indepen-
dently of each other.
Materials and methods
Since the methods used are described elsewhere (Bens
et al. 1999; Mansley and Wilson 2010b; Scott et al. 2010)
only brief details are presented here. Experiments were
undertaken using mpkCCDcl4 murine cortical collecting
duct cells grown to confluence on Costar Transwell or
Snapwell membranes (Corning, Flintshire, UK) and
deprived of hormones/growth factors for ~48 h (Bens
et al. 1999; Mansley and Wilson 2010b). Amiloride, dex-
amethasone, insulin, cyclohexamide, and general labora-
tory chemicals were from Sigma (Poole, Dorset, UK).
Antibodies against the Thr346/356/366-phosphorylated and
total forms of the protein encoded by n-myc down-
stream-regulated gene 1 (NDRG1) and the antibody
against SGK1 were provided by the MRC Protein Phos-
phorylation/Ubiquitinylation Unit (University of Dundee,
Prof. D.R. Alessi). The antibodies against the Ser473-phos-
phorylated, Thr308-phosphorylated and total forms of
protein kinase B (PKB, also known as Akt) were from
Cell Signalling (Hertfordshire, UK).
The electrometric properties of cells on Transwell
membranes were assessed using an EVOM2 epithelial
volt-ohm-meter (WPI, Hertfordshire, UK) to measure
transepithelial resistance (Rt) and voltage (Vt, relative to
earth electrode in the basolateral bath). The transepithelial
current needed to hold Vt at 0 mV (equivalent short cir-
cuit current, IEq) was then calculated (IEq = Vt/Rt). Cells
on Snapwell membranes were mounted in Ussing cham-
bers where Vt was monitored (Mansley and Wilson
2010b) under open circuit conditions. The changes in Vt
induced by the repeated, brief (20 s) injections of
transepithelial current (10 lA cm2) were also moni-
tored so that Rt (Rt = DVt/DIt) and IEq could be deter-
mined. Experiments were terminated by adding 10 lmol/
L amiloride to the apical bath, and amiloride-sensitive
short circuit current (IAmil) then calculated. Since 1 lA is
defined as 1 lC s1, we quantified electrogenic Na+ flux
(JNa) using the expression JNa = IEq 9 60/F, where F is
the Faraday constant (9.649 9 104, C mol1). Experimen-
tally induced changes in SGK1 activity were monitored by
quantifying (Western analysis) the phosphorylation of
residues (Thr346/356/366) within an endogenous protein
(NDRG1) that are phosphorylated by SGK1 but not by
other closely related kinases (Murray et al. 2004; Inglis
et al. 2009). The activity of phosphatidylinositide-OH-3-
kinase (PI3K)/phospholipid-dependent kinase 1 (PDK1)
pathway was assayed by monitoring the phosphorylation
of a residue (Thr308) within PKB that is phosphorylated
in a PI3K-dependent manner by PDK1. Similarly, the
activity of the PI3K/target of rapamycin signaling complex
2 (TORC2) pathway was assessed by monitoring the
phosphorylation status of PKB-Ser473 (Alessi et al. 1996;
Bayascas and Alessi 2005; Sarbassov et al. 2005). The
abundance of mRNA transcripts encoding SGK1 and the
ENaC a subunit (a-ENaC) were determined by real time,
quantitative PCR. RNA was therefore extracted from con-
trol/hormone-stimulated cells grown on Transwell mem-
branes (Promega SV RNA isolation kit) and 1 lg aliquots
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transcribed into cDNA using Maloney Monkey Leukemia
Virus (MMLV) reverse transcriptase. The abundance of
each target was then determined using Qiagen Quantitect
Primers and a Rotorgene Q H2M qPCR machine (Scott
et al. 2010). All experiments were undertaken using
paired experimental designs, pooled data are shown as
mean  SEM and values of n refer to the number of
times a protocol was repeated using cells at different pas-
sage. Statistical significances were tested using Student’s
paired t-test or analysis of variance (ANOVA), with Dun-
nett’s post hoc test, as appropriate.
Results
Dexamethasone induced Na+ absorption and
activation of SGK1
Studies undertaken using the epithelial volt-ohm-meter
showed that Vt and Rt were normally ~–60 mV and ~5
kO∙cm2, respectively, and analysis using Ohm’s Law
established that IEq was ~12 lA cm
2 (Fig. 1A). JNa (see
Methods) was therefore ~7.5 nmol cm2 min1. Since
~95% of the current generated by mpkCCDcl4 cells can be
blocked by amiloride (Bens et al. 1999; Mansley and Wil-
son 2010b), these data confirm that these cells absorb
Na+ via ENaC. Dexamethasone (0.1 lmol/L, 0–24 h),
hyperpolarized Vt, and reduced Rt and these effects
became apparent within ~1 h and, at the peak of the
response (6 h), the magnitude of IEq was ~4 fold greater
than control (Fig. 1A). However, after 24 h, the electrical
properties of the cells had returned to their basal values
and this response cannot, therefore, be sustained for pro-
longed periods. Subsequent analysis of protein extracted
from these cells showed that dexamethasone increased the
abundance of Thr346/356/366-phosphorylated NDRG1 with-
out altering the overall NDRG1 expression level (Fig. 1B).
This synthetic hormone thus promotes phosphorylation
of NDRG1-Thr346/356/366 (Murray et al. 2004; Inglis et al.
2009). This response became apparent within 1 h, peaked
after ~3 h and persisted for at least 24 h. Throughout this
study, we have assumed that the increased phosphoryla-
tion of NDRG1-Thr346/356/366 provides a biomarker of
increased SGK1 activity since these residues are physiolog-
ical substrates for SGK1 but not for closely related kinases
including PKB (Murray et al. 2005) and as studies of
genetically modified mice have shown that NDRG1-
Thr346/356/366 phosphorylation is abolished by deletion of
the sgk1 gene (Murray et al. 2004). However, despite the
clear increase in SGK1 activity, studies using several com-
mercially available antibodies against SGK1 failed to
detect any change to the pattern of protein expression
consistent with increased abundance of SGK1 (not
shown). We therefore undertook experiments using a
sheep antibody (S199D, 3rd bleed) against a peptide
sequence (KEAAEAFLGFSYAPPTDSFL) corresponding to
residues 412 – 431 of human SGK1. This novel antibody
was prepared within the MRC protein phosphorylation
unit (MRC-PPU, University of Dundee) and initial stud-
ies revealed strong immunoreactivity against heterolo-
gously expressed, hemagglutinin-tagged SGK1 (HA-SGK1)
and much weaker reactivity against overexpressed HA-
SGK2/3 (C.J. Hastie, MRC PPU, personal communica-
tion). In our hands this antibody consistently identified a
~48 kDa protein whose expression was strictly dependent
upon stimulation with dexamethasone. This change to the
pattern of protein expression was confirmed using a sec-
ond sheep antibody (S062D) against full-length SGK1
obtained from the same source. Initial studies using this
antibody also revealed strong immunoreactivity against
heterologously expressed SGK1 and weak reactivity
against SGK2 but not SGK3 (C.J. Hastie, MRC PPU, per-
sonal communication). While we cannot exclude the pos-
sibility that SGK2 may contribute to the immunoreactive
band detected in dexamethasone-stimulated cells, it is
important to stress that SGK2 is not usually considered
to be hormone-inducible. We therefore attribute the
increased expression of the 48 kDa band to dexametha-
sone-induced expression of SGK1. This response followed
a time course very similar to the increase in SGK1 activity
(Fig. 1C).
Dexamethasone and insulin have different
effects upon SGK1 expression
Further experiments confirmed (Mansley and Wilson
2010a, b) that dexamethasone (Fig. 2A and E) and insulin
(Fig. 2B and F) can both activate SGK1 (i.e., promote
phosphorylation of NDRG1-Thr346/356/366). However,
while dexamethasone also clearly evoked expression of
SGK1 protein (i.e., the 48 kDa protein described above
Fig. 2C and E) insulin had no effect upon the abundance
of this regulatory kinase despite the clear increase in cel-
lular SGK1 activity (Fig. 2D and F). While these data are
consistent with the idea (Wang et al. 2001; Itani et al.
2002) that dexamethasone increases cellular SGK1 activity
by evoking SGK1 synthesis, they also show that insulin
must act via a different mechanism. We therefore used
qRT–PCR (see Methods) to explore the effects of these
hormones upon sgk1 gene expression. Dexamethasone
caused an unambiguous increase (~40 fold) in the abun-
dance of SGK1 mRNA, but had no effect upon the abun-
dance of mRNA encoding a-ENaC (Fig. 3A). This was
initially surprising since a-ENaC is an important part of
the Na+ transport mechanism whose expression is regu-
lated by steroid hormones (see Sayegh et al. 1999;
McTavish et al. 2009). However, earlier work shows that
ª 2016 The Authors. Physiological Reports published by Wiley Periodicals, Inc. on behalf of
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glucocorticoid-induced a-ENaC gene transcription is a
relatively slow response and that significant increases in
mRNA abundance are not seen after only 1 h (May et al.
1997). Our data are therefore consistent with the idea that
the initiation of glucocorticoid induced Na+ transport is
dependent upon sgk1 gene expression (Wang et al. 2001;
Faletti et al. 2002). Insulin, on the other hand, had no
discernible effect upon the abundance of mRNA encoding
SGK1 or a-ENaC (Fig. 3B) and this hormone must there-
fore increase cellular SGK1 cellular activity via a mecha-
nism independent of sgk1 gene expression.
Effects of cyclohexamide on SGK1
expression
Exposing hormone-deprived cells to cyclohexamide
(10 lg mL1, 30 min pre incubation), a substance that
abolishes protein synthesis in mammalian cells, reduced
(~50%) the abundance of Thr346/356/366-phosphorylated
NDRG1 (Fig. 2A and B) without altering the overall
NDRG1 expression level (data not shown), a result which
indicates loss of cellular SGK1 activity. Although cyclo-
hexamide also seemed to reduce the abundance of SGK1
itself (Fig. 2C and D), this result is associated with con-
siderable uncertainty since SGK1 was barely detectible in
hormone-deprived cells making it difficult to quantify
changes in basal expression. While cyclohexamide did
abolish the effects of dexamethasone upon the activity
and abundance (Fig. 2E) of SGK1, it had no effect upon
the dexamethasone-induced increase in the abundance of
SGK1 mRNA (Fig. 3). Cyclohexamide also abolished the
effects of insulin upon cellular SGK1 activity (Fig. 2F).
Dexamethasone and insulin have different
effects upon cellular PI3K activity
Dexamethasone (0.1 lmol/L, 3 h) did not alter the abun-
dance of the Ser473- and Thr308-phosphorylated forms of
Figure 1. Effects of dexamethasone upon transepithelial ion transport and cellular SGK1 activity/abundance. (A) Transepithelial voltage (Vt) and
resistance (Rt) were measured across monolayers of mpkCCDcl4 cells grown on Transwell membranes following treatment with dexamethasone
(Dex, 0.1 lmol/L) over 0–24 h. Ieq was subsequently calculated using Ohm’s law. Each time point corresponds to a separate monolayer of cells,
values shown are mean  SEM (n = 4) compared by one-way analysis of variance (ANOVA), ***P < 0.001. (B) Effects of dex (0–24 h) on SGK1
activity (B) or abundance (C) determined by phosphorylated NDRG1–Thr346/356/366 and total SGK1, respectively, are shown in representative
blots. Changes to either total NDRG1 protein (B) or b–actin (C) were also monitored. Line graphs show densitometric analysis (n = 4) of
repeated blots with values shown as mean  SEM compared by one-way ANOVA/Dunnett’s post hoc test, *P < 0.05, ***P < 0.001.
2016 | Vol. 4 | Iss. 10 | e12792
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PKB (Fig. 4A,C and E) and had no effect upon the overall
PKB expression level (not shown). Since the phosphoryla-
tion status of PKB-Ser473/PKB-Thr308 provide biomarkers
of cellular PI3K activity (Kobayashi and Cohen 1999;
Bayascas and Alessi 2005; Garcıa-Martınez and Alessi
2008), these data show that dexamethasone has no effect
upon cellular PI3K activity under the present conditions.
Parallel studies of insulin-stimulated (20 nmol/L, 1 h)
cells, on other hand, revealed clear increases in the abun-
dance of Ser473- and Thr308-phosphorylated PKB (Fig. 4B,
D and F) that occurred with no change to the overall PKB
abundance (not shown). Insulin thus causes a clear
increase in cellular PI3K activity (see Cohen 2006).
Effects of cyclohexamide on PI3K
Cyclohexamide reduced (~50%) the abundance of the
Ser473- and Thr308-phosphorylated PKB (Fig. 4A–D) with-
out altering the overall PKB expression level (not shown)
and also abolished the increased phosphorylation of these
residues that is normally seen in insulin-stimulated cells
(Fig. 4B and D). Cyclohexamide therefore reduces basal
PI3K activity and abolishes the insulin-induced activation
of this regulatory kinase.
Figure 2. Dexamethasone- and insulin-induced activation of SGK1
is blocked by cyclohexamide. Representative blots of
phosphorylated protein from cells pretreated (30 min) with vehicle
or 10 lg mL1 cyclohexamide followed by addition of either (A, C,
E) dex (100 nmol/L, 3 h) or (B, D, F) insulin (20 nmol/L, 1 h), or
respective vehicle control. SGK1 activity and abundance was
assessed by monitoring the phosphorylation of NDRG1-
Thr346,356,366 (A, B) and total SGK1 (C, D). Mean densitometric
analysis of phosphorylated protein pretreated with vehicle control
(upper panels) or 10 lg mL1 cyclohexamide (lower panels)
followed by treatment with (E) dex (100 nmol/L, 3 h) or (F) insulin
(20 nmol/L, 1 h), or respective vehicle control. Values are shown as
mean  SEM, n values are denoted in brackets below bars.
Statistical significance was calculated using an unpaired t-test
between basal and stimulated conditions in the absence of CHX,
**P < 0.01, ***P < 0.001 or between basal conditions in the
absence or presence of CHX, †P < 0.05.
Figure 3. Hormone-induced changes in mRNA expression. Relative
mRNA abundance of SGK1 and a–ENaC in mpkCCDcl4 cells
measured by qRT–PCR of RNA isolated from cells following
hormonal treatment. Cells were treated with either (A)
dexamethasone (dex, 100 nmol/L) or (B) insulin (20 nmol/L) for 1 h
following pretreatment with solvent vehicle (top panels) or
10 lg mL1 cyclohexamide (CHX, lower panels) for 30 min. Values
are shown as mean  SEM, (n = 6, dex; n = 8, insulin). Statistical
significance was calculated using a paired t-test for each target
gene investigated between control and treatment group;
**P < 0.01.
ª 2016 The Authors. Physiological Reports published by Wiley Periodicals, Inc. on behalf of
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Effects of cyclohexamide – electrometric
responses
Figure 5A show values of IAmil measured in confluent
cells mounted in Ussing chambers. To analyze such data,
the current measured at the onset of each experiment
(basal IAmil) was subtracted from all subsequently
recorded data in order to isolate the changes in IAmil that
occur during each experiment. The recorded current was
normally stable (Fig. 5A) and spontaneous changes in Rt
did not occur over the time course of the present experi-
ments. Dexamethasone caused a progressive augmentation
of IAmil that became apparent after ~45 min and devel-
oped throughout the remainder of the experimental per-
iod. Analysis of the data recorded after 3 h revealed a
clear increase in the magnitude of IAmil (Fig. 5A). These
data thus confirm that dexamethasone stimulates electro-
genic Na+ absorption and further analysis established that
the dexamethasone-induced increase in JNa (DJNa) was
~10 mmol cm2 min1 (Fig. 5B). Figure 5A also includes
the data from cyclohexamide-treated (10 lg ml1,
30 min pre incubation) cells. When applied to hormone-
deprived cells, cyclohexamide caused a slowly developing
decline in the magnitude of IAmil. Rt consistently
remained above 1 kΩ∙cm2 throughout all such experi-
ments indicating that the cultured epithelial layers retain
their integrity, an observation which makes it highly unli-
kely that the cyclohexamide-induced fall in IAmil reflects a
nonspecific toxic action. We therefore conclude that
cyclohexamide causes a progressive fall in basal Na+
absorption. While such a decline also occurred in dexam-
ethasone-stimulated cells, the effect was not as marked
and analysis of the currents recorded after 3 h revealed a
clear increase in the magnitude of IAmil. While dexam-
ethasone can thus stimulate Na+ transport in the presence
of cyclohexamide the magnitude of this response was
reduced by ~50 %. Figure 5C shows the results of experi-
ments that explored the effects of cyclohexamide upon
the response to insulin. The control data confirm that
insulin augments IAmil and, as anticipated, this response
was smaller (DJNa ~5 mmol cm
2 min1) and more
rapid than the response to dexamethasone (Fig. 5C).
Although a small effect upon basal IAmil was evident,
cyclohexamide did not alter the electrometric response to
insulin (Fig 5C and D).
Discussion
The response to dexamethasone
Although SGK1 is encoded by a glucocorticoid-inducible
gene, SGK1 must be phosphorylated at Ser422 and Thr256
in order to become catalytically active and the phosphory-
lation of these physiologically important residues is cat-
alyzed by TORC2 and PDK1, respectively. Moreover,
since the activities of TORC2/PDK1 are dependent upon
PI3K (Kobayashi and Cohen 1999; Park et al. 1999;
Garcıa-Martınez and Alessi 2008; Lu et al. 2010; Mansley
and Wilson 2010a), pharmacological inhibition of PI3K
disrupts the hormonal control of ENaC by depriving the
Figure 4. Insulin-induced activation of PDK1/mTORC2 is blocked
by cyclohexamide. Representative blots of phosphorylated protein
from cells pretreated (30 min) with vehicle or 10 lg mL1
cyclohexamide followed by addition of either (A, C, E) dex
(100 nmol/L, 3 h) or (B, D, F) insulin (20 nmol/L, 1 h), or respective
vehicle control. mTORC2 and PDK1 activity were assessed by
monitoring the phosphorylation of PKB-Ser473 (A, B) and PKB-Thr308
(C, D). Mean densitometric analysis of phosphorylated protein
pretreated with vehicle control (upper panels) or 10 lg mL1
cyclohexamide (lower panels) followed by treatment with (E) dex
(100 nmol/L, 3 h) or (F) insulin (20 nmol/L, 1 h), or respective
vehicle control. Values are shown as mean  SEM, n values are
denoted in brackets below bars. Statistical significance was
calculated using an unpaired t-test between basal and stimulated
conditions in the absence of CHX, **P < 0.01, ***P < 0.001 or
between basal conditions in the absence or presence of CHX,
†P < 0.05.
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cell of SGK1 activity (Record et al. 1998; Blazer-Yost
et al. 1999; Paunescu et al. 2000; Blazer-Yost and Nofzi-
ger 2005; Inglis et al. 2009; Mansley and Wilson 2010b).
PI3K is therefore central to the hormonal control of
epithelial Na+ transport and studies of several cell types,
including epithelial cells from the ASDN, suggest that
steroid hormones can activate this regulatory kinase by
inducing transactivation of the IGF-1 receptor (Helms
et al. 2005; Holzman et al. 2007; Cascella et al. 2010;
Huang et al. 2012). These findings suggest that steroids
might increase cellular SGK1 activity via a dual mecha-
nism involving increased transcription of the sgk1 gene
and activation of PI3K. Our data show that the dexam-
ethasone-induced increase in SGK1 activity is accompa-
nied by increased abundance of SGK1 protein and
mRNA, and in contrast to earlier work (Helms et al.
2005; Holzman et al. 2007; Cascella et al. 2010; Huang
et al. 2012) we find that dexamethasone has no effect
upon cellular PI3K activity. While we cannot exclude the
possibility that dexamethasone might be able to activate
PI3K under certain conditions, it is important to stress
that our analyses of extracted protein and our electromet-
ric assays of ENaC activity were undertaken using cells
grown under identical conditions. The present data there-
fore show clearly that dexamethasone can increase cellular
SGK1 activity, and regulate Na+ transport, by evoking
SGK1 expression in the absence of any increase in PI3K
activity. While this conclusion was initially confusing
since a substantial body of earlier work shows that PI3K
is central to the control of Na+ transport (Record et al.
1998; Blazer-Yost et al. 1999; Kobayashi and Cohen 1999;
Park et al. 1999; Paunescu et al. 2000; Blazer-Yost and
Nofziger 2005; Garcıa-Martınez and Alessi 2008; Inglis
et al. 2009; Mansley and Wilson 2010b), the simplest
explanation of these findings is that the basal level of
PI3K activity is sufficient to ensure phosphorylation of
Figure 5. Inhibiting protein translation inhibits stimulation of ENaC by dexamethasone but not insulin. Amiloride-sensitive Ieq (Iamil) recorded
from cells pretreated (30 min) with vehicle or 10 lg mL1 cyclohexamide followed by addition of either (A) dex (100 nmol/L, 3 h) or (C) insulin
(20 nmol/L, 1 h), or their respective vehicle control. Traces are shown 5 min before addition of hormone. Hormonally induced Na+ was
subsequently calculated and the effects of cyclohexamide on either dex-induced Na+ flux (B) or insulin-induced Na+ flux (D) were compared.
Values are shown as mean  SEM, (n = 7 dex; n = 6 insulin). Statistical significance was calculated using an unpaired t-test between vehicle
and hormone-treated Iamil (A,C) or between hormone-induced Na
+ flux following control or CHX pretreatment (B, D); *P < 0.05, ***P < 0.001.
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SGK1. Under these conditions, changes to the abundance
of SGK1 abundance would be transduced into changes in
SGK1 activity.
The response to insulin
Previous studies of mpkCCDcl4 cells (Gonzalez-Rodriguez
et al. 2007) indicated that the magnitude of the Na+ cur-
rent induced by aldosterone and/or insulin-like growth
factor-1 (IGF-1), a peptide hormone that activates the
same signaling pathway as insulin (Cohen 2006), was pro-
portional to the abundance of SGK1 protein. While aldos-
terone did evoke SGK1 synthesis more effectively than
IGF-1, it was therefore concluded that both hormone
classes contributed to the control of SGK1 transcription
(Gonzalez-Rodriguez et al. 2007). This conclusion was,
however, primarily based upon assays of SGK1 abundance
(Gonzalez-Rodriguez et al. 2007) and an important aspect
of this study is that we also monitored cellular SGK1
activity (Murray et al. 2004; Inglis et al. 2009). Our stud-
ies clearly show that insulin-induced Na+ transport was
accompanied by an increase in cellular SGK1 activity (see
also Wang et al. 2001; Faletti et al. 2002; Gonzalez-Rodri-
guez et al. 2007). Although some authors have suggested
that insulin might regulate Na+ transport via a mecha-
nism dependent upon PKB rather than SGK1 (Lee et al.
2007; Diakov et al. 2010), earlier studies of the cells used
in the present experiments have shown that GSK650394,
a small molecule inhibitor of SGK1, suppresses insulin-
evoked Na+ transport without inactivating PKB (Mansley
and Wilson 2010b), a protein kinase that is closely related
to SGK1. Moreover, studies of SGK1-/- mice clearly
showed that insulin-evoked Na+ retention is dependent
upon SGK1 (Huang et al. 2006; Lang et al. 2006) and we
therefore conclude that the present increase in cellular
SGK1 activity is of central importance to the stimulation
of Na+ transport. However, our data also show that this
increase in cellular SGK1 activity occurred with no change
to the abundance of SGK1 protein or mRNA and so our
data, in contrast to the results of previous studies (Gon-
zalez-Rodriguez et al. 2007), indicate that insulin activates
SGK1 via a mechanism, that is, independent of increased
sgk1 expression. Although IGF-1 receptors and insulin
receptors seem to activate the same signaling pathway
(Cohen 2006), it is possible that small differences between
the properties of these receptors might underlie the dis-
crepancy with earlier work (Gonzalez-Rodriguez et al.
2007). However, the important point to emerge from our
data is that they show that it is possible for insulin to
control SGK1 activity, and Na+ transport, via a mecha-
nism that does not involve sgk1 gene transcription.
Although the responses to insulin occurred independently
of increased sgk1 gene transcription, this hormone did
activate PI3K and insulin would thus increase cellular
SGK1 activity by promoting phosphorylation of the
already present pool of SGK1. This conclusion accords
well with data from earlier studies of amphibian A6 renal
epithelial cells (Wang et al. 2001; Faletti et al. 2002) and
with recent studies in murine type II alveolar cells (Zhu
et al. 2012; He et al. 2015).
Effects of cyclohexamide
Since the responses to dexamethasone and insulin seem
to be differentiated by their requirement for synthesis of
the SGK1 protein, we explored the effects of cyclohexam-
ide, a substance known to suppress protein synthesis in
mammalian cells, upon the responses to these hormones.
The first such studies showed that cyclohexamide reduced
cellular SGK1 activity in hormone-deprived cells and this
was anticipated since the cytoplasmic half-life of SGK1 is
only ~30 min (Kobayashi and Cohen 1999; Brickley et al.
2002; Engelsberg et al. 2006). Inhibition of protein syn-
thesis would therefore deplete cellular SGK1 activity over
2–3 h. Moreover, although it had no effect upon the
abundance of SGK1 mRNA, cyclohexamide blocked the
effects of dexamethasone upon SGK1 activity and abun-
dance and this finding is consistent with the hypothesis
that dexamethasone acts by evoking sgk1 gene expression.
Electrometric studies showed that cyclohexamide caused a
slowly developing reduction in the rate of electrogenic
Na+ absorption in hormone-deprived cells. Although this
accords well with the observed fall in cellular SGK1 activ-
ity, this progressive decline in basal IAmil complicated the
analysis of these data. However, since all experiments
were undertaken using strictly paired protocols, we were
able to compare the currents recorded from hormone-
deprived and dexamethasone-treated cells. This analysis
showed that cyclohexamide caused ~ 50% inhibition of
the electrometric response to dexamethasone and, since
cyclohexamide had no effect upon the electrometric
response to insulin, these data support the idea that dex-
amethasone and insulin display a differential requirement
for SGK1 synthesis.
We were, however, surprised to observe that cyclohex-
amide also abolished the insulin-induced activation of
SGK1. Our analyses of extracted proteins provided a
physiological basis for this effect by showing that cyclo-
hexamide also reduced cellular PI3K activity and abol-
ished the effects of insulin upon this regulatory kinase.
Since it is abundantly clear that the catalytic activity of
SGK1 is critically dependent upon SGK1, these observa-
tions raise the possibility that at least some of the effects
of cyclohexamide upon SGK1 which we now report may
be secondary to loss of PI3K activity. However, the fact
that cyclohexamide can block the effects of insulin upon
2016 | Vol. 4 | Iss. 10 | e12792
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cellular SGK1 activity is difficult to reconcile with the fact
that this inhibitor of protein synthesis had no discernible
effect upon the electrometric response to this hormone.
While this observation clearly suggests that the electro-
metric response to insulin may involve mediators other
that PI3K/SGK1, this possibility is very difficult to recon-
cile with the substantial body of data which identify PI3K
as the intracellular effector that mediates responses to
insulin (see review Cohen 2006). While it is possible that
the stimulation of Na+ transport may be secondary to
increased activity of K+ channels, which would increase
the driving force for Na+ efflux via ENaC by hyperpolar-
izing the membrane potential, this does appear unlikely
since insulin appears to control K+ channel activity via a
mechanism that is dependent upon PI3K (Zaika et al.
2016). Moreover, although insulin does appear to evoke
signaling through extracellular signal-regulated kinases
(ERK1/2) via a mechanism that is independent of PI3K,
this pathway generally appears to mediate a reduction in
ENaC activity in most epithelial cell types (see review
Baines 2013). However, it is important to stress that the
protocol used in these experiments allowed us to quantify
Na+ transport continuously, whereas changes in SGK1
abundance/activity could only be quantified at the end of
each experiment after the cells had been lysed. Since the
effects of cyclohexamide will develop progressively, effects
of SGK1 activity/abundance that occur during the early
part of each experiment may not be detected. Moreover,
this finding also highlights the fact that global inhibition
of protein synthesis will have complex effects upon almost
all aspects of cellular physiology. Although these experi-
ments provided some support for the hypothesis that dex-
amethasone and insulin have different effects on protein
synthesis, they also provided inconsistent and confusing
results which suggest that it may be inappropriate to use
such a drug with such a broad mode of action to explore
such a defined aspect of cell physiology.
Conclusions
Earlier work identified SGK1 as an important part of the
mechanism that underlies the hormonal control of ENaC-
mediated Na+ retention and showed that this kinase
forms a point of convergence between the signaling path-
ways activated by insulin and by steroids (Wang et al.
2001; Gonzalez-Rodriguez et al. 2007). While our data are
consistent with earlier work which shows that glucocorti-
coids act by inducing sgk1 gene expression (Wang et al.
2001; Faletti et al. 2002; Itani et al. 2002; Gonzalez-Rodri-
guez et al. 2007), we also establish that dexamethasone
has no effect upon cellular PI3K activity. Insulin, on the
other hand, activates SGK1 via a mechanism that involves
an increase in PI3K activity but no change to sgk1 gene
expression. Although both hormones activate SGK1 and
regulate Na+ retention, these responses involve clearly dis-
tinct physiological mechanisms.
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